Key facts
- This page summarizes Jeffrey R. Balser's Form 4 filing for CVS HEALTH Corp (CVS).
- 1 reported transaction and 0 derivative rows are listed below.
- Accepted by SEC: 15 May 2026, 17:19.
Jeffrey R. Balser - 14 May 2026 Form 4 Insider Report for CVS HEALTH Corp (CVS)
- Reporting relationship
- Director
- Issuer ticker
- CVS
- Reported as of
- 14 May 2026
- Net transaction value
- $0
- SEC form
- 4
- Accepted by SEC
- 15 May 2026, 17:19:07 UTC
- Prior SEC filing
- 21 Nov 2025
- Source filing
- View source filing
- Reporting owner signature
- /s/ Jeffrey R. Balser
Source evidence
Original filing metadata and source links for verification.
4 source fields
Reporting owner
1 detail
Key filing fact
Jeffrey R. Balser filed Form 4 for CVS HEALTH Corp (CVS) on 15 May 2026.
Change
- Previous filing in this sequence was filed on 21 Nov 2025.
- Current net transaction value: $0.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reporting Owners (1)
CIK 0001751633
Primary reporting owner
Balser Jeffrey R.
- Relationship
- Director
- Address
- ONE CVS DRIVE, WOONSOCKET
- Signature
- /s/ Jeffrey R. Balser
- Signature date
- 15 May 2026
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
CVS
transaction
Common Stock
Award
- Transaction value
- Shares
- +2,058
- Change %
- +15%
- Price
- $97.15*
- Shares after
- 15,717
- Date
- 14 May 2026
- Ownership
- Direct
- Footnotes
- F1
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 1 footnote
Footnote F1
Consists of common stock issued in payment of a semi-annual retainer, at the market price, pursuant to the 2017 Incentive Compensation Plan.